Chris Walden

Download Photo

Chris Walden has been the CEO for Cancer52 since October 2024.

He was previously Deputy Director of Policy, Campaigns and Engagement at member, Blood Cancer UK and has significant experience of leading teams and building relationships to achieve change. Before this he was Head of Public Affairs for Macmillan, provided freelance public affairs consultancy and was a senior Director of the Association of Colleges.

Prior to becoming Cancer52’s CEO, Chris served as a Trustee and Chair of the Cancer52 Policy and Public Affairs Steering Group.

ABPI Patient Advisory Council

The ABPI Patient Advisory Council - made up of eight chief executives or members of the executive leadership team from across UK patient organisations, provides ABPI Board Members and Senior Executive Team with meaningful patient engagement to inform strategy, policy priorities and work-plans across the ABPI.

ABPI Patient Advisory Council

Last modified: 12 December 2024

Last reviewed: 12 December 2024